Predictors of Bone Metastases at 68Ga-PSMA-11 PET/CT in Hormone-Sensitive Prostate Cancer (HSPC) Patients with Early Biochemical Recurrence or Persistence
Guido Rovera(Università Cattolica del Sacro Cuore), Désirèe Deandreis, Umberto Ricardi(University of Turin), Marco Oderda(University of Turin), Séréna Grimaldi(Université Paris-Saclay), Roberto Passera(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Sara Dall’Armellina(University of Turin), Paolo Gontero(Fondazione Ricerca Molinette), Alessia Guarneri(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Giuseppe Carlo Iorio(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino)
Cited by 7
Related Papers
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k
Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation
|The Lancet Oncology|2020|1.1k
Selumetinib-Enhanced Radioiodine Uptake in Advanced Thyroid Cancer
|New England Journal of Medicine|2013|825
Defining oligometastatic disease from a radiation oncology perspective: An ESTRO-ASTRO consensus document
|Radiotherapy and Oncology|2020|646